National Institute for Health and Welfare in Finland, THL, has analysed persistent organic pollutants (POPs) from samples of the two large pregnancy cohorts, SELMA and Life Child. POPs are organic chemical compounds which bioaccumulate in animals and humans. They include both 1) intentionally produced chemicals that are currently or were once used in agriculture, disease control, manufacturing, or industrial processes; and 2) unintentionally produced chemicals that are a result of some industrial processes or combustion.

THL’s chemical analysis group has measured 22 persistent organic pollutants (POPs) from 2373 SELMA serum samples from Sweden and 331 LIFE Child serum samples from Germany. Results of these samples have been used in statistical analysis to define which ones of these POPs are so-called “bad actors”, i.e. which ones are associated with adverse health effects addressed in this project. Those that were associated (hexachlorobenzene and p,p’-DDE) were added to experimental mixtures in concentration proportions that appeared in the serum samples of the pregnant women. The experimental mixtures will be further used in different cell and animal experiments to study their effects on sexual development, neurodevelopment and growth and metabolism.

Figures below show the comparison of HCB and p,p’-DDE in Swedish and German serum samples.

Figure 1. Mean HCB concentrations in SELMA (SWE) and LIFE Child (GER) grouped by sampling years and age of the mothers.

Figure 2. Mean p,p’-DDE concentrations in SELMA (SWE) and LIFE Child (GER) grouped by sampling years and age of the mothers.

Hexachlorobenzene (HCB) has previously been used as pesticide and small amounts are still also formed as by-product of industrial processes and combustion, whereas p,p’-DDE is the major metabolite of classical pesticide p,p’-DDT. The use of both HCB and p,p’-DDT is banned under the Stockholm Convention but limited use of p,p’-DDT in disease vector control continues, because of its effectiveness in reducing malarial infections, balanced by environmental and other health concerns.


Prof. Wieland Kiess, a partner in EDC-MixRisk project, is one of the main authors of the recently published research paper which has brought attention to the issue of Endocrine Disruptive Chemicals (EDCs) in Germany. The article, entitled in English “Endocrine disruptors: Evidence from epidemiological studies necessitates a critical review of model systems”, was published in a Federal German Health Journal, Bundesgesundheitsblatt.

The paper addresses adverse health effects of EDCs and depicts the epidemiological findings for EDC-caused effects in the fields of growth and metabolism, neurocognitive development and sexual development and reproduction. It also discusses the clinical importance of epigenetic changes caused by the action of EDCs during vulnerable phases of development.

Prof. Kiess says: “Epidemiological studies are often criticized because their reproducibility is not always guaranteed, but they remain the method of choice for the development and analysis of suitable model systems. Positive associations, in spite of sometimes conflicting results, are key in the selection of factors that can then be analysed in model systems in an unbiased way.”

Furthermore, the article highlights the need for closer linkage between epidemiological studies and mechanistic research into model systems, especially focusing on the interaction of different EDCs and the consequences of prenatal and early life exposure.

The original article was published in German. The abstract is available in English via this link.

Wieland Kiess is professor of paediatrics and director of the Hospital for Children and Adolescents of the University of Leipzig since 1998. He is PI of the German LIFE Child study cohort and actively involved especially in the project’s Work Package 2
, Epidemiology and biostatistics. His main research interests include chronic diseases in early life, interaction between environment, genes and society.

EDC-MixRisk was represented by Dr. Mattias Öberg (Karolinska Institutet/Swetox) at the WHO Chemical Risk Assessment Network meeting that was organized in Parma, Italy 20-22 June 2017.

The meeting, hosted by the European Food Safety Authority (EFSA), assembled 83 top organizations within the field of chemical risk assessment from all regions world wide. Development of a capacity building strategy was a major focus of the meeting, and other themes addressed included combined exposures to multiple chemicals, human biomonitoring, identifying new and emerging risks and new scientific approaches for regulatory safety assessment.

Furthermore, a new WHO publication titled “Chemical Mixtures in Source-water and Drinking-water” was launched at the meeting. The document provides an overview of available tools and practical recommendations to support the assessment and management of risks to human health associated with chemical mixtures in drinking-water and its sources.

WHO/IPCS also presented a report on public health impact of chemicals (2016), according to which it is estimated that 1.3 million lives and 43 million disability-adjusted life-years were lost in 2012 due to exposures to selected chemicals. However, data are only available for a small number of chemical exposures and people are exposed to many more chemicals every day.

A week before the network meeting, the issue of chemical health and environment was recognized at the highest political level. The Sixth Ministerial Conference on Environment and Health recently adopted the Ostrava Declaration (15 June 2017, Ostrava), aiming to e.g. promote actions on “minimizing the adverse effects of chemicals on human health and the environment; reducing the exposure of vulnerable groups to hazardous chemicals, particularly during the early stages of human development; strengthening capacities for risk assessment and research to secure a better understanding of human exposure to chemicals and the associated burden of disease; and applying the precautionary principle where appropriate”.

WHO Chemical Risk Assessment Network is a voluntary collaborative initiative whose overall goal is to improve chemical risk assessment globally through facilitating sustainable interaction between institutions on chemical risk assessment issues. The Network has been established to enhance global efforts to assess risks to human health from exposure to chemicals.

More information about the WHO network and its activities:

Meet our EDC-MixRisk scientists and hear their story on what they are researching and why it matters. Joachim Sturve is assoc. professor and lecturer at the Department of Biological and Environmental Sciences at the University of Gothenburg, Sweden. He is an ecotoxicologist and the main focus of his research is on the effects of pollutants in aquatic organisms, primarily fish.

Hi Joachim – What your research group is researching in the experimental module of EDC-MixRisk?

We are studying the effects of EDC mixtures in fish, primarily zebrafish. The zebrafish genome matches approximately 70% to human orthologs, and they serve as a model species for biomedical research. Our work in EDC-MixRisk is divided into two parts. First, acute exposures with the aim to identify modes of action and possible biomarkers for this kind of exposures. Second, long-term transgenerational exposures with the aim to find epigenetic effects of EDC mixture. F0 generation of fish has been fed with low levels of EDC mixtures from larval stage until sexual maturity. Epigenetic alteration will be studied in the F1 and F2 generations.


What have you discovered so far and what your first results indicate?

The short turn acute studies have generated a lot of fascinating results and it is evident that the thyroid system is affected by these mixtures. We have identified specific components (genes) in the thyroid system which might be interesting for future studies. Epigenetic alterations in F1 and F2 generations will be studied during the fall of 2017.


What are the potential implications of your findings in a bigger picture?

In EDC-MixRisk, the various cell and animal models will be applied to epidemiological findings from two independent human cohorts. This gives a unique opportunity for collective data analysis comparing the reliability of experimental models in reproducing human health effects. Our results then again contribute to adding one more piece of the puzzle when it comes to EDCs effects on the thyroid system. They will hopefully also generate possible biomarkers for future screening and monitoring, which is relevant for risk assessment.


EDC-MixRisk will organize a workshop in Brussels, 25-26 September 2017. The aim of the workshop is to discuss the Adverse Outcome Pathway (AOP) approach and to explore the approach from the EDC-MixRisk perspective. The second day of the workshop will focus especially on aspects of societal impact and building key messages based on recent research results.

The EDC-MixRisk Consortium came together for its annual meeting in Stockholm, 15-17 May, to discuss the project’s progress and future activities.

The meeting was organized as a three-day event, combining an 1) Adverse Outcome Pathway  (AOP) workshop 2) a joint meeting between EDC-MixRisk and EDC-2020 to present scientific results and 3) one and half days dedicated for the EDC-MixRisk Consortium discussions.

The meeting was a great opportunity to learn more about an AOP approach and get highlights and glimpses of scientific results generated within the two projects, EDC-MixRisk and EDC-2020. Furthermore, the meeting provided a great forum to share lessons learned as well as to receive feedback and to discuss further ideas and plans with the Members of the Scientific Advisory Board.

The programme of the last one and half days of the meeting gave an overview of the project progress and on the tasks within the different modules. Also an update on management and dissemination activities was presented. The module breakout sessions drilled into the challenges, future plans and details of the work which were reported on the final day of the meeting.

The first results generated within the project have demonstrated the validity of project’s integrated approach – interaction between epidemiology and experimental toxicology, and the need to take mixture effects into account for risk assessment. It was summarized that overall, the project is progressing well and is largely on track in terms of its tasks and timeline.

The 2018 Consortium meeting will be held again in Stockholm, the hometown of the Project Coordinator, Prof. Åke Bergman.







EDC-MixRisk is a four-year project financed through the EU Commission’s programme Horizon 2020, which started in the spring of 2015. It involves participation from six Swedish Swetox-universities, as well as five European and one American. The project focuses on the effects of mixtures of endocrine disruptive chemicals (EDCs) on children.

The interdisciplinary and integrated research approach of EDC-MixRisk includes:

  • epidemiology of two child cohorts focused on three health domains (growth and metabolism, neurodevelopment, and sexual development)
  • a web of experimental toxicology and molecular biology approaches to determine multiple adverse health outcomes with pathways starting at the molecular level during early life exposure to EDC mixtures
  • regulatory toxicology for development of a transparent and systematic risk assessment framework. Together this interdisciplinary research, integrating epidemiologic and experimental evidence, will facilitate assessment of risk and societal impact ensuring better risk management for EDCs and their mixtures.


EDC-2020 is a five-year research program on endocrine disrupting chemicals financed by approx. one million euro a year by the Swedish Research Council Formas on behalf of the Swedish Government. The core of the project is five research areas and a training program. Eleven Swedish Swetox-universities have joint together in the efforts of EDC-2020.

EDC-2020 aims to:

  • create an enabling environment for strong research on EDCs and for scientific advances and innovations, which will benefit the field of toxicology-related sciences as a whole.
  • establish an overarching national program for research on EDCs, optimizing cooperation between national universities as well as with the Swetox facilities in Södertälje, and improve interdisciplinary research.
  • establish an international EDC collaboration platform including world-leading experts and to link students in toxicological sciences across the country.

The research performed in EDC-MixRisk helps to expand our knowledge on mixtures of endocrine disrupting chemicals. Meet our EDC-MixRisk scientists and hear their story on what they are doing and why it is important. This time in line is Efthymia Kitraki (PhD), professor of Biology and Head of the Laboratory of Basic Biomedical Sciences, in the School of Health Sciences University of Athens, Greece. Her experimental approaches include in vivo manipulations and behavioural testing of small rodents, followed by in vitro analysis of the tissues using cellular and molecular techniques.

What is the focus of your research group in EDC-MixRisk?

Our research group is studying the effects of in utero exposure of mice to mixtures of EDCs. The exposed offspring of both sexes are tested at postnatal days 21(weaning) and 90 (adulthood).

We are mainly interested in the potential effects of Mixture N1 (neurodevelopment) on the neuroendocrine axis of stress response.

Additional goals are: investigation of the potential effects of Mixture G1 (growth and metabolism) on the development of brain areas implicated in cognition and of Mixture S (sexual development) on the gonadal function.

What have you discovered so far?

We had a first set of mixtures, mixtures G0 (growth and metabolism), N0 (neurodevelopment), and S0 (sexual development) as they, in the respective dilution, reflect a “typically-measured” mixture of EDCs in the SELMA mothers. Given the inability to use Mixtures N0 and G0 (due to different kinetics of persistent and non-persistent compounds in the same mixture) we are presently studying the effects of Mix S0. Anogenital distance (AGD) is used as a measurement of genital development. Preliminary results show alterations in AGD and AGD/bw (AGD index), especially in male offspring at concentrations 0.4mM and 4mM of Mix S0 (stock 1M), but not at 20mM. Experiments are ongoing by exposing animals at 0.02mM (corresponds to SELMA levels). Analyses of gonadal histology and expression of steroidogenesis- and differentiation-related genes are in process.

What are the potential implications of your findings?

The detected alterations in AGD index are in line with those observed in the SELMA study for the boys exposed in utero to a mixture comprised mainly by the same ‘bad’ chemicals. Our preliminary data are also in compliance with the literature on the effects of individual components of our Mixture S0 in rodents. The observed alterations of AGD index, a biomarker of prenatal exposure to endocrine disruptors, if linked to molecular/hormonal indices of gonadal dysfunction in our study, could provide a pathway of adversity due to exposure to this mixture.


2nd International Fresenius MIXTOX Conference “Toxicity of Chemical Mixtures: Risk, Hazard and Exposure Assessment” will be organized in Cologne, Germany 8‐9 June 2017. Prof. Åke Bergman, EDC-MixRisk Coordinator, will give some insights and provide an overview of EDC-MixRisk at the conference. The title of his talk is EDC-MixRisk – a novel approach for assessing EDCs.

More information and programme of the conferece is available here.

A very recently published study carried out by CNRS flags that exposure to endocrine disrupting chemicals (EDCs) causes changes in thyroid hormone signalling, which may disturb brain development. Frog embryos were exposed to a mixture of 15 chemicals commonly present in the fluid of a human mother’s womb.

The results of the study demonstrate that a short exposure to the mixture (3 days) affected thryoid hormone signalling, but also altered brain gene expression, reduced neuron volume and inhibited tadpole movement. Furthermore, these findings can be placed in the context of recent epidemiological studies showing that small variations in maternal thyroid hormone during early pregnancy impact children’s IQ.

Professor Barbara Demeneix, an author of the paper and work package leader in EDC-MixRisk, says:

“Undisturbed thyroid signalling is essential for normal brain development in all vertebrates. Since thyroid hormone is exactly the same in frogs and humans, these findings should prompt rapid action to remove these harmful chemicals from the market.”


The results are published by Nature in a peer-reviewed paper in Scientific Reports entitled “Human amniotic fluid contaminants alter thyroid hormone signalling and early brain development in Xenopus embryos”. The full article is available here.